Platform Trial For Cryptococcal Meningitis

NCT06666322 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Hiv
Cryptococcal Meningitis

Interventions

DRUG: Standard of care
DRUG: Oteseconazole - antifungal therapy 1
DRUG: Sfu-AM2-19 Injection - antifungal therapy 2
DRUG: Antifungal therapy 3
DRUG: Antifungal therapy 4

Sponsor

University of Minnesota